HALO
Halozyme Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD78.60
+1.51 (+1.96%)
Rating:B+
Company Profile
CEO
Helen I. Torley
IPO Date
2004-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$76.96
Prev. Close
$77.09
Day Low
$76.96
Day High
$78.63
52W Low
$56.05
52W High
$82.26
Market Cap
$9.32B
Volume
1.22M